The estimated Net Worth of Joseph B Ii Richey is at least $437 Thousand dollars as of 6 May 2013. Joseph Richey owns over 1,000 units of Invacare stock worth over $437,144 and over the last 21 years Joseph sold IVC stock worth over $0.
Joseph has made over 7 trades of the Invacare stock since 2004, according to the Form 4 filled with the SEC. Most recently Joseph bought 1,000 units of IVC stock worth $13,740 on 6 May 2013.
The largest trade Joseph's ever made was exercising 25,500 units of Invacare stock on 12 August 2009 worth over $476,595. On average, Joseph trades about 1,430 units every 42 days since 2003. As of 6 May 2013 Joseph still owns at least 662,340 units of Invacare stock.
You can see the complete history of Joseph Richey stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44036.
Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon, and Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: